RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY

被引：0
|
作者：
Katsumata, N. [1 ]
Fujiwara, Y. [1 ]
Katakami, N. [2 ]
Nishiwaki, Y. [3 ]
Tsuboi, M. [4 ]
Takeda, K. [5 ]
Nakanishi, T. [6 ]
Ichinose, Y. [7 ]
Kawahara, Y. [8 ]
Hotta, T. [6 ]
Saijo, N. [9 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Natl Canc Ctr Hosp E, Chiba, Japan
[4] Tokyo Med Univ Hosp, Tokyo, Japan
[5] Osaka City Gen Hosp, Osaka, Japan
[6] Nagoya Med Ctr, Natl Hosp Org, Aichi, Japan
[7] Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan
[8] Chuo Chest Med Ctr, Natl Hosp Org Kinki, Osaka, Japan
[9] Kinki Univ, Sch Med, Osaka 589, Japan
来源：
VOX SANGUINIS | 2009年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [41] Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy
    Elizabeth Hovey
    Paul de Souza
    Gavin Marx
    Phillip Parente
    Tal Rapke
    Andrew Hill
    Antonino Bonaventura
    Antony Michele
    Paul Craft
    Ehtesham Abdi
    Andrew Lloyd
    Supportive Care in Cancer, 2014, 22 : 1233 - 1242
  • [42] Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy
    Hovey, Elizabeth
    de Souza, Paul
    Marx, Gavin
    Parente, Phillip
    Rapke, Tal
    Hill, Andrew
    Bonaventura, Antonino
    Michele, Antony
    Craft, Paul
    Abdi, Ehtesham
    Lloyd, Andrew
    SUPPORTIVE CARE IN CANCER, 2014, 22 (05) : 1233 - 1242
  • [43] Multivariate regression analyses of data from a randomized, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy
    Fallowfield, L
    Gagnon, D
    Zagari, M
    Cella, D
    Bresnahan, B
    Littlewood, TJ
    McNulty, P
    Gorzegno, G
    Freund, M
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1341 - 1353
  • [44] An international, randomized, double-blind, placebo-controlled phase III dose-comparison study to evaluate weekly intramuscular administration of alefacept in patients with chronic plaque psoriasis
    Christophers, E
    Bourcier, M
    Griffiths, C
    Guenther, L
    Langley, R
    Lebwohl, M
    Lowe, N
    Ortonne, JP
    Dubertret, L
    Rizova, E
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 571 - 576
  • [45] Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regiments of darbepoetin alfa in patients with heart failure and anaemia: reply
    van Veldhuisen, Dirk J.
    Wasserman, Scott M.
    Baker, Nigel
    EUROPEAN HEART JOURNAL, 2008, 29 (04) : 566 - 567
  • [46] Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
    Lowell L. Hart
    Renata Ferrarotto
    Zoran G. Andric
    J. Thaddeus Beck
    Janakiraman Subramanian
    Davorin Z. Radosavljevic
    Bojan Zaric
    Wahid T. Hanna
    Raid Aljumaily
    Taofeek K. Owonikoko
    Didier Verhoeven
    Jie Xiao
    Shannon R. Morris
    Joyce M. Antal
    Maen A. Hussein
    Advances in Therapy, 2021, 38 : 350 - 365
  • [47] Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
    Hart, Lowell L.
    Ferrarotto, Renata
    Andric, Zoran G.
    Beck, J. Thaddeus
    Subramanian, Janakiraman
    Radosavljevic, Davorin Z.
    Zaric, Bojan
    Hanna, Wahid T.
    Aljumaily, Raid
    Owonikoko, Taofeek K.
    Verhoeven, Didier
    Xiao, Jie
    Morris, Shannon R.
    Antal, Joyce M.
    Hussein, Maen A.
    ADVANCES IN THERAPY, 2021, 38 (01) : 350 - 365
  • [48] A phase III randomized, double-blinded, placebo-controlled study of suvemcitug combined with chemotherapy for platinum-resistant ovarian cancer (SCORES).
    Yuan, Guangwen
    Wu, Lingying
    Li, Qingshui
    Lou, Ge
    Li, Jundong
    Liu, Xiaowei
    Wang, Danbo
    Yang, Chen
    Sun, Shuguang
    Zhang, Jiajing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA5516 - LBA5516
  • [49] A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse
    Vergote, Ignace
    Armstrong, Deborah
    Scambia, Giovanni
    Teneriello, Michael
    Sehouli, Jalid
    Schweizer, Charles
    Weil, Susan C.
    Bamias, Aristotelis
    Fujiwara, Keiichi
    Ochiai, Kazunori
    Poole, Christopher
    Gorbunova, Vera
    Wang, Wenquan
    O'Shannessy, Daniel
    Herzog, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2271 - +
  • [50] A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer
    Schwartzberg, LS
    Yee, LK
    Senecal, FM
    Charu, V
    Tomita, D
    Wallace, J
    Rossi, G
    ONCOLOGIST, 2004, 9 (06): : 696 - 707
12345